ATRC (AtriCure) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATRC AtriCure Inc ATRC
79 GF Score
Price $37.37
GF Value $40.12
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is AtriCure Short-term investments?

Short-term investments only applies to insurance companies.

ATRC
79GF Score
AtriCure Inc ATRC
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be undervalued. The current stock price of $37.37 is trading 6.9% below its estimated GF Value™ of $40.12. GuruFocus considers AtriCure to be Fairly Valued.

Key valuation signals for ATRC:

  • Short-term investments:
  • GF Value™: $40.12 vs. price of $37.37 (6.9% below fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtriCure Business Description

Other Exchanges A5I:Germany
Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
79GF Score

Get the complete analysis for ATRC

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.37
Price
$40.12
GF Value